LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
BioCentury Podcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
Events
All Events
East-West Healthcare Reception
Bio€quity Europe
Grand Rounds — U.S.
Grand Rounds — Europe
China Healthcare Summit
East-West Biopharma Summit 2026
Bio€quity Europe 2026
Podcast: The BioCentury Show
Podcast: BioCentury This Week
Webinars
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a company name.
REQUEST A FREE TRIAL
Overview
Pipeline
Deals
Financings
Articles
Gelesis Inc.
Headquarters:
Boston, MA, United States
Website:
http://www.gelesis.com
Year Founded:
2006
Status:
Private
BioCentury
|
Jul 20, 2021
Deals
July 19 Quick Takes: Woodline, RA lead $88.5M series B for Frontier
Plus: COVID vaccine under review, a SPAC for Gelesis, Anthos’ Factor XI
Read More
BioCentury
|
Jun 19, 2020
Product Development
June 18 Quick Takes: Approvals for Ultragenyx, Epizyme, Merck; plus Tecfidera tussle, Tecentriq in TNBC, Sarepta-Selecta, and Gelesis goes to China
Read More
BioCentury
|
Apr 15, 2019
Company News
Gelesis' weight loss aid gains U.S. approval
Read More
BioCentury
|
Jan 11, 2019
Product R&D
PureTech turns inward
How PureTech is transitioning from the affiliate model to an internal pipeline
Read More
BioCentury
|
Nov 16, 2018
Clinical News
Gelesis submits device application to FDA for hydrogel weight loss product
Read More
BioCentury
|
Jun 5, 2018
Company News
Management tracks: Sarepta, Gilead
Read More
BioCentury
|
Sep 29, 2017
Clinical News
Gelesis reports mixed data for hydrogel weight loss product
Read More
BioCentury
|
Sep 25, 2017
Clinical News
Gelesis reports mixed data for hydrogel weight loss product
Read More
BioCentury
|
Jan 4, 2016
Financial News
Gelesis withdraws IPO
Read More
BioCentury
|
Dec 21, 2015
Financial News
Gelesis completes venture financing
Read More
Items per page:
10
1 - 10 of 24
Help Center
Username
Request Training
Submit Data Correction
Ask a Question
Elevio by Dixa
Help